SCHEMBL6754258

SCHEMBL6754258

CCCCCC1=C(C2=C(CCCCC)C(=O)C=CC2=O)C(=O)C=CC1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.50
BACE1 P56817 1/20 0.50
ALOX5 P09917 19/20 0.44
MPEG1 Q2M385 7/20 0.44
XIAP P98170 2/20 0.44
GPR84 Q9NQS5 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
PTGES O14684 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
TP53 P04637 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655350 0.89 ACHE (0.55) ACHEBACE1ALOX5MPEG1XIAP
Hydrochloric Acid SCHEMBL28922225 0.84 ACHE (0.57) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL6754278 0.84 ACHE (0.53) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL7866839 0.81 ACHE (0.47) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL21814448 0.79 ACHE (0.47) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL9889220 0.79 ACHE (0.47) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL8933270 0.78 ACHE (0.50) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL5554116 0.78 ALOX5 (0.62) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL21814670 0.78 ACHE (0.50) ACHEBACE1ALOX5MPEG1XIAP
SCHEMBL21814489 0.78 ACHE (0.50) ACHEBACE1ALOX5MPEG1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828347-B2 Reacting a hydroxyquinone anion with a first quinone possessing a first directing group at a C-2 of the first quinone and a second directing group at a C-3 of the first quinone and obtaining a biquinone ILLINOIS INSTITUTE OF TECHNOLOGY 2004-12-07 US disclosed
US-20040087663-A1 Anti-viral multi-quinone compounds and regiospecific synthesis thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087663-A1 Anti-viral multi-quinone compounds and regiospecific synthesis thereof NQO1, QTRT1, NQO2 ACHE 4537/4885BACE1 2911/4885ALOX5 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.